Keybank National Association Ampio Pharmaceuticals, Inc. Transaction History

Keybank National Association

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2017 May 14, 2018	SELL	N/A	-3,500 Reduced 4.76%	70,000 $56,000
Q4 2016 May 14, 2018	BUY	N/A	73,500	73,500 $66,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.